211 related articles for article (PubMed ID: 18300006)
1. Motor neuron disease associated with multiple myeloma.
Koc F; Paydas S; Yerdelen D; Demirkiran M
Int J Neurosci; 2008 Mar; 118(3):337-41. PubMed ID: 18300006
[TBL] [Abstract][Full Text] [Related]
2. [Amyotrophic lateral sclerosis in a patient with Waldenstrom's macroglobulinemia].
Vannucci P; Castiglioni M; Filidei M; Riccioni N
Minerva Med; 1997 Apr; 88(4):167-70. PubMed ID: 9182260
[TBL] [Abstract][Full Text] [Related]
3. Riluzole therapy for motor neurone disease: an early Australian experience (1996-2002).
Zoing MC; Burke D; Pamphlett R; Kiernan MC
J Clin Neurosci; 2006 Jan; 13(1):78-83. PubMed ID: 16410201
[TBL] [Abstract][Full Text] [Related]
4. [Association between motoneuron disease and Waldenström macroglobulinemia].
Di Saverio A; Quaglino D
Recenti Prog Med; 2001 Sep; 92(9):530-2. PubMed ID: 11552308
[TBL] [Abstract][Full Text] [Related]
5. [Amyotrophic lateral sclerosis with multiple myeloma].
Masi MC; Gironelli L; Bonuccelli U; Cei G; Meucci G; Giraldi C
Riv Neurol; 1990; 60(5):167-70. PubMed ID: 2100033
[TBL] [Abstract][Full Text] [Related]
6. Motor neuron syndromes in cancer patients.
Forsyth PA; Dalmau J; Graus F; Cwik V; Rosenblum MK; Posner JB
Ann Neurol; 1997 Jun; 41(6):722-30. PubMed ID: 9189033
[TBL] [Abstract][Full Text] [Related]
7. Audit of outcomes in motor neuron disease (MND) patients treated with riluzole.
Mitchell JD; O'brien MR; Joshi M
Amyotroph Lateral Scler; 2006 Jun; 7(2):67-71. PubMed ID: 16753969
[TBL] [Abstract][Full Text] [Related]
8. Preface: the state of the science of all motor neuron diseases.
Weiss MD; Carter GT
Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):xix-xx. PubMed ID: 18625405
[No Abstract] [Full Text] [Related]
9. Inclusion body myopathy associated with motor neuron syndrome: three case reports.
Cafforio G; Pistolesi S; D'Avino C; Galluzzi F; Patricelli A; Solito B; Fontanini G; Siciliano G
Clin Neuropathol; 2005; 24(1):36-41. PubMed ID: 15696783
[TBL] [Abstract][Full Text] [Related]
10. [Paraproteinemia and motor neuron disease].
Saito T; Irie S; Ito H; Kowa H
Rinsho Shinkeigaku; 1992 Oct; 32(10):1146-8. PubMed ID: 1297563
[TBL] [Abstract][Full Text] [Related]
11. Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease.
Ishiyama T; Okada R; Nishibe H; Mitsumoto H; Nakayama C
Brain Res; 2004 Sep; 1019(1-2):226-36. PubMed ID: 15306257
[TBL] [Abstract][Full Text] [Related]
12. The ALS/MND prevalence in Sweden estimated by riluzole sales statistics.
Nygren I; Antonova K; Mattsson P; Askmark H
Acta Neurol Scand; 2005 Mar; 111(3):180-4. PubMed ID: 15691287
[TBL] [Abstract][Full Text] [Related]
13. Motor neuron disease.
Jackson CE; Rosenfeld J
Phys Med Rehabil Clin N Am; 2001 May; 12(2):335-52, ix-x. PubMed ID: 11345011
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of riluzole: who are the patients enrolled in the studies?
Logroscino G; Zoccolella S
Amyotroph Lateral Scler; 2007 Apr; 8(2):124-5; author reply 125. PubMed ID: 17453643
[No Abstract] [Full Text] [Related]
15. Motor neuron disease, lymphoproliferative disease, and bone marrow biopsy.
Louis ED; Hanley AE; Brannagan TH; Sherman W; Murphy P; Lange DJ; Trojaborg W; Younger DS; Lovelace RE; Latov N; Rowland LP
Muscle Nerve; 1996 Oct; 19(10):1334-7. PubMed ID: 8808660
[TBL] [Abstract][Full Text] [Related]
16. Riluzole: a glimmer of hope in the treatment of motor neurone disease.
Kiernan MC
Med J Aust; 2005 Apr; 182(7):319-20. PubMed ID: 15804220
[TBL] [Abstract][Full Text] [Related]
17. Chronic lymphocytic leukemia and lymphosarcoma associated with multiple myeloma: report of three cases.
Narasimhan P; Jagathambal K; Elizalde AM; Rosner F
Arch Intern Med; 1975 May; 135(5):729-32. PubMed ID: 1053274
[TBL] [Abstract][Full Text] [Related]
18. Lymphoproliferative disorders and motor neuron disease: an update.
Gordon PH; Rowland LP; Younger DS; Sherman WH; Hays AP; Louis ED; Lange DJ; Trojaborg W; Lovelace RE; Murphy PL; Latov N
Neurology; 1997 Jun; 48(6):1671-8. PubMed ID: 9191785
[TBL] [Abstract][Full Text] [Related]
19. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
Conde B; Winck JC; Azevedo LF
Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082
[TBL] [Abstract][Full Text] [Related]
20. [B lymphoproliferative syndrome with characteristics common to chronic lymphatic leukemia, Waldenström disease and plasmacytic leukemia].
Tosato F; Fossaluzza V; Sala P; Tonutti E
Minerva Med; 1984 Nov; 75(44):2691-4. PubMed ID: 6440066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
